A prospective randomized open-label trial of sirolimus versus paclitaxel-coated balloons for the side branch of de novo coronary bifurcation lesion
In patients with <i>de novo</i> non-left main coronary bifurcation lesions treated with provisional stenting in the SB, SB dilation with SCB was non-inferior to PCB in terms of percentage of TLS at 9-month follow-up.<b>Trial Registration:</b> This study was registered at the National Research Registration and Filing Information System (https://www.medicalresearch.org.cn/, MR-12-24-007528).
Authors
- Ranzun Zhao (ORCID: https://orcid.org/0009-0003-6320-8968)
- Rui Jing
- Haiqiang Sang (ORCID: https://orcid.org/0000-0001-6328-570X)
- C L Li
- Xiantao Song
- Xiaomin Chen (ORCID: https://orcid.org/0000-0003-1498-0452)
- Chi Liu (ORCID: https://orcid.org/0000-0002-2539-6916)
- Zuyi Yuan
- Qiyue Gao (ORCID: https://orcid.org/0009-0000-3808-3495)
- Guidong Xu (ORCID: https://orcid.org/0009-0003-7860-105X)
- Xiaoping null Peng
- Qiyuan Xu
- Hong Jiang
Institutions
- Nanchang University (CN)
- Zunyi Medical University (CN)
- Capital Medical University (CN)
- TEDA International Cardiovascular Hospital (CN)
- Wuhan University (CN)
- Suzhou Municipal Hospital (CN)
- Beijing Anzhen Hospital (CN)
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Renmin Hospital of Wuhan University (CN)
- Ningbo University Affiliated Hospital (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- First Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2025-12-01
- DOI
- https://doi.org/10.21037/jtd-2025-1243
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00